Health Scope

Published by: Kowsar

Prevalence of Depression Among Iranian Women with Breast Cancer: A Systematic Review and Meta-Analysis

Abbas Rezaianzadeh 1 , Masoume Mousave 2 , Soheil Hassanipour 3 , Ahmad Maghsoudi 2 , Ali Mohammad Mokhtari 4 and Seyedeh Leila Dehghani 5 , *
Authors Information
1 Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
3 Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran
4 Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
5 Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran
Article information
  • Health Scope: May 31, 2019, 8 (2); e62781
  • Published Online: May 12, 2019
  • Article Type: Review Article
  • Received: October 11, 2017
  • Revised: October 22, 2018
  • Accepted: November 20, 2018
  • DOI: 10.5812/jhealthscope.62781

To Cite: Rezaianzadeh A, Mousave M, Hassanipour S, Maghsoudi A, Mokhtari A M, et al. Prevalence of Depression Among Iranian Women with Breast Cancer: A Systematic Review and Meta-Analysis, Health Scope. 2019 ; 8(2):e62781. doi: 10.5812/jhealthscope.62781.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7-30. doi: 10.3322/caac.21442. [PubMed: 29313949].
  • 2. Ataollahi MR, Sharifi J, Paknahad MR, Paknahad A. Breast cancer and associated factors: A review. J Med Life. 2015;8(Spec Iss 4):6-11. [PubMed: 28316699]. [PubMed Central: PMC5319297].
  • 3. Azubuike SO, Muirhead C, Hayes L, McNally R. Rising global burden of breast cancer: The case of sub-Saharan Africa (with emphasis on Nigeria) and implications for regional development: A review. World J Surg Oncol. 2018;16(1):63. doi: 10.1186/s12957-018-1345-2. [PubMed: 29566711]. [PubMed Central: PMC5863808].
  • 4. Shulman LN, Willett W, Sievers A, Knaul FM. Breast cancer in developing countries: Opportunities for improved survival. J Oncol. 2010;2010:595167. doi: 10.1155/2010/595167. [PubMed: 21253541]. [PubMed Central: PMC3021855].
  • 5. Youlden DR, Cramb SM, Yip CH, Baade PD. Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med. 2014;11(2):101-15. doi: 10.7497/j.issn.2095-3941.2014.02.005. [PubMed: 25009752]. [PubMed Central: PMC4069805].
  • 6. Enayatrad M, Amoori N, Salehiniya H. Epidemiology and trends in breast cancer mortality in Iran. Iran J Public Health. 2015;44(3):430-1. [PubMed: 25905094]. [PubMed Central: PMC4402429].
  • 7. Azgomi S, Rezaianzadeh A, Mokhtari A, Maghsoudi A, Nazarzadeh M, Dehghani S, et al. The incidence of breast cancer in Iran: A systematic review and meta-analysis. J Anal Oncol. 2016;5(4):139-45. doi: 10.6000/1927-7229.2016.05.04.2.
  • 8. Rezaianzadeh A, Jalali M, Maghsoudi A, Mokhtari AM, Azgomi SH, Dehghani SL. The overall 5-year survival rate of breast cancer among Iranian women: A systematic review and meta-analysis of published studies. Breast Dis. 2017;37(2):63-8. doi: 10.3233/BD-160244. [PubMed: 28655117].
  • 9. VandeKieft GK. Breaking bad news. Am Fam Physician. 2001;64(12):1975-8. [PubMed: 11775763].
  • 10. Boswell EN, Dizon DS. Breast cancer and sexual function. Transl Androl Urol. 2015;4(2):160-8. doi: 10.3978/j.issn.2223-4683.2014.12.04. [PubMed: 26816822]. [PubMed Central: PMC4708123].
  • 11. Kraus PL. Body image, decision making, and breast cancer treatment. Cancer Nurs. 1999;22(6):421-7. quiz 428-9. doi: 10.1097/00002820-199912000-00004. [PubMed: 10603689].
  • 12. Izci F, Ilgun AS, Findikli E, Ozmen V. Psychiatric symptoms and psychosocial problems in patients with breast cancer. J Breast Health. 2016;12(3):94-101. doi: 10.5152/tjbh.2016.3041. [PubMed: 28331743]. [PubMed Central: PMC5351486].
  • 13. Pasquini M, Biondi M. Depression in cancer patients: A critical review. Clin Pract Epidemiol Ment Health. 2007;3:2. doi: 10.1186/1745-0179-3-2. [PubMed: 17288583]. [PubMed Central: PMC1797173].
  • 14. Rosenblatt L, Block SD. Depression, decision making, and the cessation of life-sustaining treatment. West J Med. 2001;175(5):320-5. doi: 10.1136/ewjm.175.5.320. [PubMed: 11694480]. [PubMed Central: PMC1071609].
  • 15. Ng CG, Mohamed S, Kaur K, Sulaiman AH, Zainal NZ, Taib NA, et al. Perceived distress and its association with depression and anxiety in breast cancer patients. PLoS One. 2017;12(3). e0172975. doi: 10.1371/journal.pone.0172975. [PubMed: 28296921]. [PubMed Central: PMC5351853].
  • 16. Tsaras K, Papathanasiou IV, Mitsi D, Veneti A, Kelesi M, Zyga S, et al. Assessment of depression and anxiety in breast cancer patients: Prevalence and associated factors. Asian Pac J Cancer Prev. 2018;19(6):1661-9. doi: 10.22034/APJCP.2018.19.6.1661. [PubMed: 29938451]. [PubMed Central: PMC6103579].
  • 17. Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci. 2011;13(1):7-23. [PubMed: 21485743]. [PubMed Central: PMC3181964].
  • 18. Park EM, Rosenstein DL. Depression in adolescents and young adults with cancer. Dialogues Clin Neurosci. 2015;17(2):171-80. [PubMed: 26246791]. [PubMed Central: PMC4518700].
  • 19. Schneiderman N, Ironson G, Siegel SD. Stress and health: Psychological, behavioral, and biological determinants. Annu Rev Clin Psychol. 2005;1:607-28. doi: 10.1146/annurev.clinpsy.1.102803.144141. [PubMed: 17716101]. [PubMed Central: PMC2568977].
  • 20. Stults-Kolehmainen MA, Sinha R. The effects of stress on physical activity and exercise. Sports Med. 2014;44(1):81-121. doi: 10.1007/s40279-013-0090-5. [PubMed: 24030837]. [PubMed Central: PMC3894304].
  • 21. Mukherjee A, Mazumder K, Kaushal V, Ghoshal S. Effect of supportive psychotherapy on mental health status and quality of life of female cancer patients receiving chemotherapy for recurrent disease. Indian J Palliat Care. 2017;23(4):399-402. doi: 10.4103/IJPC.IJPC_73_17. [PubMed: 29123345]. [PubMed Central: PMC5661341].
  • 22. Smith HR. Depression in cancer patients: Pathogenesis, implications and treatment (Review). Oncol Lett. 2015;9(4):1509-14. doi: 10.3892/ol.2015.2944. [PubMed: 25788991]. [PubMed Central: PMC4356432].
  • 23. Mashhadi MA, Shakiba M, Zakeri Z. Evaluation of depression in patients with cancer in south of Iran (Zahedan). Iran J Cancer Prev. 2013;6(1):12-6. [PubMed: 25250104]. [PubMed Central: PMC4142906].
  • 24. Nikbakht HA, Aminisani N, Hosseini SR, Asghari Jafarabadi M, Ahoei K. [Prevalence of anxiety and depression in patients with colorectal cancer in Babol-north of Iran (2008-12)]. J Gorgan Univ Med Sci. 2016;18(1):101-7. Persian.
  • 25. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ. 2009;339:b2700. doi: 10.1136/bmj.b2700. [PubMed: 19622552]. [PubMed Central: PMC2714672].
  • 26. Joanna Briggs Institute. Critical appraisal checklist for analytical cross sectional studies. Adelaide: The Joanna Briggs Institute; 2017.
  • 27. Harris RJ, Deeks JJ, Altman DG, Bradburn MJ, Harbord RM, Sterne JAC. Metan: Fixed-and random-effects meta-analysis. Stata J Promoting Commun Stat Stata. 2018;8(1):3-28. doi: 10.1177/1536867x0800800102.
  • 28. Bagos PG, Nikolopoulos GK. Mixed-effects poisson regression models for meta-analysis of follow-up studies with constant or varying durations. Int J Biostatistics. 2009;5(1). doi: 10.2202/1557-4679.1168.
  • 29. Taghavi M, Kalafi E, Talei A, Dehbozorgi G, Taghavi SM. Investigating the relation of depression and religious coping and social support in women with breast cancer. J Isfahan Med Sch. 2011;28(115).
  • 30. Musarezaie A, Momeni-GhaleGhasemi T, Gorji M. Survey the anxiety and depression among breast cancer patients referred to the specialized Isfahan hospital of cancer. Iran J Health Syst Res. 2014;10(1):39-48.
  • 31. Ardebil MD, Bouzari Z, Shenas MH, Keighobadi M. Depression and health related quality of life in breast cancer patients. J Pak Med Assoc. 2013;63(1):69-71. [PubMed: 23865135].
  • 32. Nikbakhsh N, Moudi S, Abbasian S, Khafri S. Prevalence of depression and anxiety among cancer patients. Caspian J Intern Med. 2014;5(3):167-70. [PubMed: 25202445]. [PubMed Central: PMC4143739].
  • 33. Ramezani T. Degree of depression and the need for counseling among women with breast cancer in Kerman chemotherapeutic centers. Iran J Psychiatr Clin Psychol. 2001;6(4 (24)).
  • 34. Montazeri A, Sajadian A, Ebrahimi M, Akbari ME. Depression and the use of complementary medicine among breast cancer patients. Support Care Cancer. 2005;13(5):339-42. doi: 10.1007/s00520-004-0709-z. [PubMed: 15549425].
  • 35. Shakeri J, Abdoli NA, Paianda M, Chareh-Gar G. The frequency of depression among patients with breast cancer in Kermaneshah UMS chemotherapy centers in 2007. J Med Counc Islamic Republic Iran. 2009;27(3).
  • 36. Derakhshanfar A, Niayesh A, Abbasi M, Ghalaeeha A, Shojaee M. Frequency of depression in breast cancer patients: A study in Farshchian and Besat Hospitals of Hamedan during 2007-8. Iran J Surg. 2013;21(2):68-74.
  • 37. Saadat S, Yousefifard M, Asady H, Moghadas Jafari A, Fayaz M, Hosseini M. The most important causes of death in Iranian population; a retrospective cohort study. Emerg (Tehran). 2015;3(1):16-21. [PubMed: 26512364]. [PubMed Central: PMC4614603].
  • 38. Khazaei S, Mansori K, Soheylizad M, Gholamaliee B, Shadmani FK, Khazaei Z, et al. Epidemiology of lung cancer in Iran: Sex difference and geographical distribution. Middle East J Cancer. 2017;8(4):223-8.
  • 39. Hassanipour S, Fathalipour M, Salehiniya H. The incidence of prostate cancer in Iran: A systematic review and meta-analysis. Prostate Int. 2018;6(2):41-5. doi: 10.1016/j.prnil.2017.11.003. [PubMed: 29922630]. [PubMed Central: PMC6004615].
  • 40. Hassanipour S, Namvar G, Fathalipour M, Salehiniya H. The incidence of kidney cancer in Iran: A systematic review and meta-analysis. Biomedicine (Taipei). 2018;8(2):9. doi: 10.1051/bmdcn/2018080209. [PubMed: 29806587]. [PubMed Central: PMC5992926].
  • 41. Rezaianzadeh A, Mokhtari AM, Hassanipour S, Maghsoudi A, Dehghani SL, Nazarzadeh M, et al. The age-standardized incidence rate of ovarian cancer in iranian women: A systematic review and meta-analysis. Middle East J Cancer. 2018;9(3):171-8.
  • 42. Arab-Zozani M, Fathalipour M, Abdzadeh E, Joukar F, Mohseni S, Mansour-Ghanaei F, et al. The incidence of esophageal cancer in Iran: A systematic review and meta-analysis. Biomed Res Ther. 2018;5(7):2493-503. doi: 10.15419/bmrat.v5i7.459.
  • 43. Khazaei S, Rezaeian S, Khazaei Z, Molaeipoor L, Nematollahi S, Lak P, et al. National breast cancer mortality and incidence rates according to the human development index: An ecological study. Adv Breast Cancer Res. 2016;5(1):30-6. doi: 10.4236/abcr.2016.51003.
  • 44. Akechi T, Nakano T, Okamura H, Ueda S, Akizuki N, Nakanishi T, et al. Psychiatric disorders in cancer patients: Descriptive analysis of 1721 psychiatric referrals at two Japanese cancer center hospitals. Jpn J Clin Oncol. 2001;31(5):188-94. doi: 10.1093/jjco/hye039. [PubMed: 11450992].
  • 45. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;(32):57-71. doi: 10.1093/jncimonographs/lgh014. [PubMed: 15263042].
  • 46. Pirl WF. Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monogr. 2004;(32):32-9. doi: 10.1093/jncimonographs/lgh026. [PubMed: 15263039].
  • 47. Chen X, Zheng Y, Zheng W, Gu K, Chen Z, Lu W, et al. Prevalence of depression and its related factors among Chinese women with breast cancer. Acta Oncol. 2009;48(8):1128-36. doi: 10.3109/02841860903188650. [PubMed: 19863220]. [PubMed Central: PMC3771388].
  • 48. Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H. Incidence and mortality of breast cancer and their relationship to development in Asia. Asian Pac J Cancer Prev. 2015;16(14):6081-7. doi: 10.7314/APJCP.2015.16.14.6081. [PubMed: 26320499].
  • 49. Zainal NZ, Nik-Jaafar NR, Baharudin A, Sabki ZA, Ng CG. Prevalence of depression in breast cancer survivors: A systematic review of observational studies. Asian Pac J Cancer Prev. 2013;14(4):2649-56. doi: 10.7314/APJCP.2013.14.4.2649. [PubMed: 23725190].
  • 50. Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18(4):743-53. doi: 10.1200/JCO.2000.18.4.743. [PubMed: 10673515].
  • 51. Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW. Inflammation and behavioral symptoms after breast cancer treatment: Do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol. 2011;29(26):3517-22. doi: 10.1200/JCO.2011.36.1154. [PubMed: 21825266]. [PubMed Central: PMC3179252].
  • 52. Karakoyun-Celik O, Gorken I, Sahin S, Orcin E, Alanyali H, Kinay M. Depression and anxiety levels in woman under follow-up for breast cancer: Relationship to coping with cancer and quality of life. Med Oncol. 2010;27(1):108-13. doi: 10.1007/s12032-009-9181-4. [PubMed: 19225913].
  • 53. Vahdaninia M, Omidvari S, Montazeri A. What do predict anxiety and depression in breast cancer patients? A follow-up study. Soc Psychiatry Psychiatr Epidemiol. 2010;45(3):355-61. doi: 10.1007/s00127-009-0068-7. [PubMed: 19458878].
  • 54. Keramatinia A, Hassanipour S, Nazarzadeh M, Wurtz M, Monfared AB, Khayyamzadeh M, et al. Correlation between nitrogen dioxide as an air pollution indicator and breast cancer: A systematic review and meta-analysis. Asian Pac J Cancer Prev. 2016;17(1):419-24. doi: 10.7314/APJCP.2016.17.1.419. [PubMed: 26838249].
  • 55. Alcalar N, Ozkan S, Kucucuk S, Aslay I, Ozkan M. Association of coping style, cognitive errors and cancer-related variables with depression in women treated for breast cancer. Jpn J Clin Oncol. 2012;42(10):940-7. doi: 10.1093/jjco/hys119. [PubMed: 22859828].
  • 56. Mehnert A, Berg P, Henrich G, Herschbach P. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology. 2009;18(12):1273-80. doi: 10.1002/pon.1481. [PubMed: 19267364].
  • 57. Lueboonthavatchai P. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J Med Assoc Thai. 2007;90(10):2164-74. [PubMed: 18041438].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments